title: Crucial role of calcium-sensing receptor activation in cardiac injury of diabetic rats.
abstract: Cardiac injury is a common pathological change frequently accompanied by diabetes mellitus. Recently, some evidence indicated that calcium-sensing receptor (CaSR) expressed in the cardiac tissue. However, the functional role of CaSR in diabetic cardiac injury remains unclear. The present study was designed to investigate the relationship between CaSR activation and diabetes-induced cardiac injury. Diabetic model was successfully established by administration of streptozotocin (STZ) in vivo, and cardiomyocyte injury was simulated by 25.5 mM glucose in vitro. Apoptotic rate, intracellular calcium concentration ([Ca²⁺](i)) and the expression of Bcl-2, Bax, extracellular signal-regulated protein kinase (ERK), c-Jun NH₂-terminal protein kinase (JNK), and p38 were examined. We demonstrated a significant increase in left ventricular end-diastolic pressure (LVEDP) as well as decrease in maximum rate of left ventricular pressure rise and fall (±dp/dtmax), and left ventricular systolic pressure (LVSP), apoptosis of cardiomyocytes was also observed by TUNEL staining. In vitro, 25.5 mM glucose-induced apoptosis was detected by flow cytometry in neonatal rat cardiomyocytes. Further results showed that 25.5 mM glucose significantly increased [Ca²⁺](i), up-regulated the expression of Bax, P-ERK and P-JNK, and suppressed Bcl-2 expression. However, the above deleterious changes were further confirmed when co-treatment with CaSR agonist GdCl₃ (300 µM). But the effects of GdCl₃ were attenuated by 10 µM NPS-2390, a specific CaSR inhibitor. When CaSR was silence by siRNA transfection, the effects of high glucose were inhibited. These results suggest that CaSR activation could lead to the apoptosis of cardiomyocytes in diabetic cardiac injury through the induction of calcium overload, the activation of the mitochondrial, and mitogen-activated protein kinase pathway.
authors.affiliation: Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
authors.forename: Hanping
authors.initials: H
authors.lastname: Qi
authors.forename: Yonggang
authors.initials: Y
authors.lastname: Cao
authors.forename: Wei
authors.initials: W
authors.lastname: Huang
authors.forename: Yang
authors.initials: Y
authors.lastname: Liu
authors.forename: Ye
authors.initials: Y
authors.lastname: Wang
authors.forename: Lei
authors.initials: L
authors.lastname: Li
authors.forename: Lijuan
authors.initials: L
authors.lastname: Liu
authors.forename: Zhong
authors.initials: Z
authors.lastname: Ji
authors.forename: Hongli
authors.initials: H
authors.lastname: Sun
mesh_terms: D000818:Animals; D017209:Apoptosis; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D002118:Calcium / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D005434:Flow Cytometry; D006331:Heart Diseases / Q000209:etiology* / Q000503:physiopathology; D006439:Hemodynamics; D020287:In Situ Nick-End Labeling; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D044169:Receptors, Calcium-Sensing / Q000378:metabolism / Q000502:physiology*; D013311:Streptozocin; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D044169:Receptors, Calcium-Sensing; D051028:bcl-2-Associated X Protein; D013311:Streptozocin; D002118:Calcium